Trinity Biotech (TRIB) Interest Coverage Ratio Growth (1y) (2010 - 2024)
Trinity Biotech (TRIB) Interest Coverage Ratio Growth (1y) (2010 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -45.18% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 3.52% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 59.82% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -80.85% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 11.06% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 189.50% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -54.61% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -6.18% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Trinity Biotech | 93,750.00 | -5.04 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -66.20% |
| Sep 30, 2024 | -56.00% |
| Jun 30, 2024 | -63.22% |
| Mar 31, 2024 | 649.80% |
| Dec 31, 2023 | 52.52% |
| Sep 30, 2023 | -49.36% |
| Jun 30, 2023 | 1,642.96% |
| Mar 31, 2023 | 1,444.09% |
| Dec 31, 2022 | -1,715.44% |
| Sep 30, 2022 | 283.06% |
| Jun 30, 2022 | 239.46% |
| Mar 31, 2022 | 103.91% |
| Dec 31, 2021 | 97.47% |
| Sep 30, 2021 | 72.80% |
| Jun 30, 2021 | 61.05% |
| Mar 31, 2021 | -85.11% |
| Dec 31, 2020 | -535.53% |
| Sep 30, 2020 | -587.72% |
| Jun 30, 2020 | 57.88% |
| Mar 31, 2020 | -29.40% |